Trinity Biotech Welcomes New Chief Commercial Officer
Trinity Biotech appoints Adrian Donohue as CCO, aiming for growth with new HIV product and CGM market entry.
- Latest
- Trending
Trinity Biotech appoints Adrian Donohue as CCO, aiming for growth with new HIV product and CGM market entry.
Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.